Treatment Strategies for Co-Occurring ADHD and Substance Use Disorders

REFERENCES

• Olfson M. Diagnosing mental disorders in office-based pediatric practice. J Dev Behav Pediatr. 1992;13:363–365.
   PubMed Web of Science ®Google Scholar
• Barbaresi WJ, Katusic SK, Colligan RC, , et al How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn. Arch Pediatr Adolesc Med. 2002;156:217–224.
   PubMedGoogle Scholar
• Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004;27:187–201.
   PubMed Web of Science ®Google Scholar
• Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 2000;157:816–818.
   PubMed Web of Science ®Google Scholar
• Rasmussen P, Gillberg C. Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. J Am Acad Child Adolesc Psychiatry. 2000;39:1424–1431.
   PubMed Web of Science ®Google Scholar
• Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002;111:279–289.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Adler LA, Barkley R, , et al Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry. 2005;57:1442–1451.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Adler L, Barkley R, , et al The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163:716–723.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617–627.
   PubMed Web of Science ®Google Scholar
• Weiss M, Murray C. Assessment and management of attention-deficit hyperactivity disorder in adults. CMAJ. 2003;168:715–722.
   PubMed Web of Science ®Google Scholar
• Murphy K, Barkley RA. Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry. 1996;37:393–401.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Adler L, Ames M, , et al The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med. 2005;47:565–572.
   PubMed Web of Science ®Google Scholar
• Regier DA, Farmer ME, Rae DS, , et al Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264:2511–2518.
   PubMed Web of Science ®Google Scholar
• Kessler RC, McGonagle KA, Zhao S, , et al Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19.
   PubMed Web of Science ®Google Scholar
• Grant BF, Harford TC. Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Alcohol Depend. 1995;39:197–206.
   PubMed Web of Science ®Google Scholar
• Grant BF, Stinson FS, Dawson DA, , et al Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61:807–816.
   PubMed Web of Science ®Google Scholar
• Levin FR, Evans SM, Kleber HD. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend. 1998;52:15–25.
   PubMed Web of Science ®Google Scholar
• Clure C, Brady KT, Saladin ME, Johnson D, Waid R, Rittenbury M. Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice. Am J Drug Alcohol Abuse. 1999;25:441–448.
   PubMed Web of Science ®Google Scholar
• Schubiner H, Tzelepis A, Milberger S, , et al Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry. 2000;61:244–251.
   PubMed Web of Science ®Google Scholar
• Halikas JA, Meller J, Morse C, Lyttle MD. Predicting substance abuse in juvenile offenders: attention deficit disorder versus aggressivity. Child Psychiatry Hum Dev. 1990;21:49–55.
   PubMed Web of Science ®Google Scholar
• Thompson LL, Riggs PD, Mikulich SK, Crowley TJ. Contribution of ADHD symptoms to substance problems and delinquency in conduct-disordered adolescents. J Abnorm Child Psychol. 1996;24:325–347.
   PubMed Web of Science ®Google Scholar
• DeMilio L. Psychiatric syndromes in adolescent substance abusers. Am J Psychiatry. 1989;146:1212–1214.
   PubMed Web of Science ®Google Scholar
• Berkson J. Limitations of the application of fourfold table analyses to hospital data. Biometrics Bulletin. 1946;2:47–53.
   Google Scholar
• Greenhill LL, Halperin JM, Abikoff H. Stimulant medications. J Am Acad Child Adolesc Psychiatry. 1999;38:503–512.
   PubMed Web of Science ®Google Scholar
• Shenker A. The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder: focus on catecholamine receptor pharmacology. Adv Pediatr. 1992;39:337–382.
   Google Scholar
• Schubiner H, Saules KK, Arfken CL, , et al Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol. 2002;10:286–294.
   PubMed Web of Science ®Google Scholar
• Greenhill LL, Swanson JM, Steinhoff K, , et al A pharmacokinetic/pharmacodynamic study comparing a single morning dose of Adderall to twice-daily dosing in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2003;42:1234–1241.
   PubMed Web of Science ®Google Scholar
• Ebstein RP, Nemanov L, Klotz I, Gritsenko I, Belmaker RH. Additional evidence for an association between the dopamine D4 receptor (D4DR) exon III repeat polymorphism and the human personality trait of Novelty Seeking. Mol Psychiatry. 1997;2:472–477.
   PubMed Web of Science ®Google Scholar
• LaHoste GJ, Swanson JM, Wigal SB, , et al Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry. 1996;1:121–124.
   PubMed Web of Science ®Google Scholar
• Cook EH, Jr., Stein MA, Krasowski MD, , et al Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet. 1995;56:993–998.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Wang GJ, Fowler JS, Ding YS. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57:1410–1415.
   PubMed Web of Science ®Google Scholar
• Giedd JN, Blumenthal J, Molloy E, Castellanos FX. Brain imaging of attention deficit/hyperactivity disorder. Ann NY Acad Sci. 2001;931:33–49.
   PubMed Web of Science ®Google Scholar
• Bush G, Frazier JA, Rauch SL, , et al Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry. 1999;45:1542–1552.
   PubMed Web of Science ®Google Scholar
• Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res. 1998;94:127–152.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Wang G, Fowler JS, , et al Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci. 2001;21:RC121.
   PubMed Web of Science ®Google Scholar
• Kiyatkin EA, Rebec GV. Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats. J Neurophysiol. 1996;75:142–153.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Swanson JM. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry. 2003;160:1909–1918.
   PubMed Web of Science ®Google Scholar
• Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005;162:1403–1413.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003;111:179–185.
   PubMed Web of Science ®Google Scholar
• Ernst M, Luckenbaugh DA, Moolchan ET, , et al Behavioral predictors of substance-use initiation in adolescents with and without attention-deficit/hyperactivity disorder. Pediatrics. 2006;117:2030–2039.
   PubMed Web of Science ®Google Scholar
• Molina BS, Pelham WE, Jr. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol. 2003;112:497–507.
   PubMed Web of Science ®Google Scholar
• McGough JJ, Barkley RA. Diagnostic controversies in adult attention deficit hyperactivity disorder. Am J Psychiatry. 2004;161:1948–1956.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 2000.
   Google Scholar
• Milin R, Loh E, Chow J, Wilson A. Assessment of symptoms of attention-deficit hyperactivity disorder in adults with substance use disorders. Psychiatr Serv. 1997;48:1378–1380,1395.
   Web of Science ®Google Scholar
• Mannuzza S, Klein RG, Klein DF, Bessler A, Shrout P. Accuracy of adult recall of childhood attention deficit hyperactivity disorder. Am J Psychiatry. 2002;159:1882–1888.
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders. Patient ed., SCID-I/P, Version 2.0. New York: New York State Psychiatric Institute, Biometrics Research Department; 1995.
   Google Scholar
• Conners CK, Erhardt JN, Epstein D, Parker JDA, Sitarenios G, Sparrow E. Self-rating of ADHD symptoms in adults: I. Factor structure and normative data. J Atten Disord. 1999;3:141–151.
   Google Scholar
• DuPaul G. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York, NY: Guilford Press; 1998.
   Google Scholar
• Swanson J. SNAP-IV Scale. Irvine, Calif.: University of California Child Development Center; 1994.
   Google Scholar
• Mannuzza S, Klein RG. Long-term prognosis in attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am. 2000;9:711–726.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Biederman J, Mick E. Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict. 1998;7:156–163.
   PubMed Web of Science ®Google Scholar
• Carroll KM, Rounsaville BJ. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry. 1993;34:75–82.
   PubMed Web of Science ®Google Scholar
• Wise BK, Cuffe SP, Fischer T. Dual diagnosis and successful participation of adolescents in substance abuse treatment. J Subst Abuse Treat. 2001;21:161–165.
   PubMed Web of Science ®Google Scholar
• White AM, Jordan JD, Schroeder KM, , et al Predictors of relapse during treatment and treatment completion among marijuana-dependent adolescents in an intensive outpatient substance abuse program. Subst Abuse. 2004;25:53–59.
   PubMedGoogle Scholar
• Levin FR, Evans SM, Vosburg SK, Horton T, Brooks D, Ng J. Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addict Behav. 2004;29:1875–1882.
   PubMed Web of Science ®Google Scholar
• Brunton LL, Lazo JS, Parker KL. Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 2006.
   Google Scholar
• Spencer T, Biederman J, Wilens T, , et al Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2001;58:775–782.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2004;24:24–29.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Results from the 2002 National Survey on Drug Use and Health: National Findings. NHSDA Series H-22, DHHS Publication No. SMA 03*3836. Rockville, Md.: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2003.
   Google Scholar
• Fredericks EM, Kollins SH. Assessing methylphenidate preference in ADHD patients using a choice procedure. Psychopharmacology (Berl). 2004;175:391–398.
   PubMed Web of Science ®Google Scholar
• Stoops WW, Glaser PE, Fillmore MT, Rush CR. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. J Psychopharmacol. 2004;18:534–543.
   PubMed Web of Science ®Google Scholar
• Rush CR, Essman WD, Simpson CA, Baker RW. Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans. J Clin Psychopharmacol. 2001;21:273–286.
   PubMed Web of Science ®Google Scholar
• Hart CL, Ward AS, Haney M, Foltin RW, Fischman MW. Methamphetamine self-administration by humans. Psychopharmacology (Berl). 2001;157:75–81.
   PubMed Web of Science ®Google Scholar
• Roache JD, Grabowski J, Schmitz JM, Creson DL, Rhoades HM. Laboratory measures of methylphenidate effects in cocaine-dependent patients receiving treatment. J Clin Psychopharmacol. 2000;20:61–68.
   PubMed Web of Science ®Google Scholar
• Kollins SH, Rush CR, Pazzaglia PJ, Ali JA. Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate. Exp Clin Psychopharmacol. 1998;6:367–374.
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Biederman J, Ciccone PE, , et al PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. Am J Psychiatry. 2006;163:387–395.
   PubMed Web of Science ®Google Scholar
• Levin FR, Evans SM, McDowell DM, Kleber HD. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychiatry. 1998;59:300–305.
   PubMed Web of Science ®Google Scholar
• Somoza EC, Winhusen TM, Bridge TP, , et al An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder. J Addict Dis. 2004;23:77–92.
   PubMed Web of Science ®Google Scholar
• Levin FR, Evans SM, Brooks DJ, Kalbag AS, Garawi F, Nunes EV. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend. 2006;81:137–148.
   PubMed Web of Science ®Google Scholar
• Levin FR, Evans SM, Brooks DJ, Garawi F. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug Alcohol Depend. in press.
   Google Scholar
• Levin FR, Evans SM, McDowell DM, Brooks DJ, Nunes E. Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder. J Addict Dis. 2002;21:1–16.
   PubMed Web of Science ®Google Scholar
• Grabowski J, Rhoades H, Schmitz J, , et al Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol. 2001;21:522–526.
   PubMed Web of Science ®Google Scholar
• Shearer J, Wodak A, van Beek I, Mattick RP, Lewis J. Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction. 2003;98:1137–1141.
   PubMed Web of Science ®Google Scholar
• Shearer J, Wodak A, Mattick RP, , et al Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence. Addiction. 2001;96:1289–1296.
   PubMed Web of Science ®Google Scholar
• White R. Dexamphetamine substitution in the treatment of amphetamine abuse: an initial investigation. Addiction. 2000;95:229–238.
   PubMed Web of Science ®Google Scholar
• Grabowski J, Rhoades H, Stotts A, , et al Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology. 2004;29:969–981.
   PubMed Web of Science ®Google Scholar
• Adler LA, Spencer TJ, Milton DR, Moore RJ, Michelson D. Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis. J Clin Psychiatry. 2005;66:294–299.
   PubMed Web of Science ®Google Scholar
• Michelson D, Adler L, Spencer T, , et al Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry. 2003;53:112–120.
   PubMed Web of Science ®Google Scholar
• Wolraich ML, Wibbelsman CJ, Brown TE, , et al Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics. 2005;115:1734–1746.
   PubMed Web of Science ®Google Scholar
• Conners CK, Casat CD, Gualtieri CT, , et al Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry. 1996;35:1314–1321.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Spencer TJ, Biederman J, , et al A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry. 2001;158:282–288.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Haight BR, Horrigan JP, , et al Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Biol Psychiatry. 2005;57:793–801.
   PubMed Web of Science ®Google Scholar
• Motavalli Mukaddes N, Abali O. Venlafaxine in children and adolescents with attention deficit hyperactivity disorder. Psychiatry Clin Neurosci. 2004;58:92–95.
   Google Scholar
• Olvera RL, Pliszka SR, Luh J, Tatum R. An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. J Child Adolesc Psychopharmacol. 1996;6:241–250.
   PubMed Web of Science ®Google Scholar
• Connor DF, Fletcher KE, Swanson JM. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999;38:1551–1559.
   PubMed Web of Science ®Google Scholar
• Taylor FB, Russo J. Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2001;21:223–228.
   PubMed Web of Science ®Google Scholar
• Biederman J, Swanson JM, Wigal SB, Boellner SW, Earl CQ, Lopez FA. A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study. J Clin Psychiatry. 2006;67:727–735.
   PubMed Web of Science ®Google Scholar
• Greenhill LL, Biederman J, Boellner SW, , et al A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006;45:503–511.
   PubMed Web of Science ®Google Scholar
• Swanson JM, Greenhill LL, Lopez FA, , et al Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. J Clin Psychiatry. 2006;67:137–147.
   PubMed Web of Science ®Google Scholar
• Taylor FB, Russo J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J Child Adolesc Psychopharmacol. 2000;10:311–320.
   PubMed Web of Science ®Google Scholar
• Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology. 2005;30:205–211.
   PubMed Web of Science ®Google Scholar
• Biederman J, Spencer T, Wilens T. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2004;7:77–97.
   PubMed Web of Science ®Google Scholar
• Castaneda R, Levy R, Hardy M, Trujillo M. Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults. Psychiatr Serv. 2000;51:169–171.
   PubMed Web of Science ®Google Scholar
• Riggs PD. Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry. 1998;37:331–332.
   PubMed Web of Science ®Google Scholar
• Grabowski J, Roache JD, Schmitz JM, Rhoades H, Creson D, Korszun A. Replacement medication for cocaine dependence: methylphenidate. J Clin Psychopharmacol. 1997;17:485–488.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Gignac M, Swezey A, Monuteaux MC, Biederman J. Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry. 2006;45:408–414.
   PubMed Web of Science ®Google Scholar
• Gordon SM, Tulak F, Troncale J. Prevalence and characteristics of adolescents patients with co-occurring ADHD and substance dependence. J Addict Dis. 2004;23:31–40.
   PubMed Web of Science ®Google Scholar
• Williams RJ, Goodale LA, Shay-Fiddler MA, Gloster SP, Chang SY. Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents. Am J Addict. 2004;13:381–389.
   PubMed Web of Science ®Google Scholar
• Ciccone PE. Attempted abuse of concerta. J Am Acad Child Adolesc Psychiatry. 2002;41:756.
   PubMedGoogle Scholar
• Hechtman L, Abikoff H, Klein RG, , et al Children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment: impact on parental practices. J Am Acad Child Adolesc Psychiatry. 2004;43:830–838.
   PubMed Web of Science ®Google Scholar
• Abikoff H, Hechtman L, Klein RG, , et al Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry. 2004;43:820–829.
   PubMed Web of Science ®Google Scholar
• Safren SA, Otto MW, Sprich S, Winett CL, Wilens TE, Biederman J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther. 2005;43:831–842.
   PubMed Web of Science ®Google Scholar
• Hesslinger B, Tebartz van Elst L, Nyberg E, , et al Psychotherapy of attention deficit hyperactivity disorder in adults—a pilot study using a structured skills training program. Eur Arch Psychiatry Clin Neurosci. 2002;252:177–184.
   PubMed Web of Science ®Google Scholar
• Stevenson CS, Whitmont S, Bornholt L, Livesey D, Stevenson RJ. A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder. Aust N Z J Psychiatry. 2002;36:610–616.
   PubMed Web of Science ®Google Scholar
• Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend. 2006;81:313–322.
   PubMed Web of Science ®Google Scholar
• Conners CK. Clinical use of rating scales in diagnosis and treatment of attention-deficit/hyperactivity disorder. Pediatr Clin North Am. 1999;46:857–870.
   PubMed Web of Science ®Google Scholar